Tulane study finds potential treatment for eosinophilic esophagitis

FHS
July 31, 2023
12:17 pm

A new study from Tulane University has identified a new treatment for a chronic immune system disease that can prevent children from eating.

ChatGPT passes the nutrition test, but experts remain irreplaceable

ChatGPT offers accurate nutritional advice aligned with international guidelines for managing non-communicable diseases, yet struggles with complex patient scenarios.

February 8, 2024

Risk Adjusted Net Present Value: What is the current valuation of Oncolytics Biotech’s Reolysin

The revenue for Reolysin is expected to reach an annual total of $109 mn by 2038 globally based off GlobalData’s Expiry Model. The drug’s revenue

September 19, 2023

Counseling for PAD Walking Issues Might Hold Cardiovascular Benefit

While counseling about walking did not increase step counts for people with peripheral artery disease (PAD), it still was linked to cardiovascular prevention in a

August 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.